HepaRegeniX
Small molecule MKK4 inhibitors developer to treat acute and chronic liver diseases.
Company Operating Status
Active
Country
Crunchbase URL
Email Address
info@heparegenix.com
Founded Date
2017
Headquarters
Latest Funding Round Date
April 15, 2025
Latest Funding Round Amount (USD)
24,000,000
Latest Funding Type
LinkedIn URL
Location
Number of Employees (Ranges)
1 – 10
Patents Assigned (Count)
1
Phone Number
+4970717912810
Pitchbook URL
Total Funding Amount (USD)
61,600,000
Official Website
Find more companies like HepaRegeniX
Use the Golden Query Tool to find similar companies in the same industry, location, or by any other field in the Knowledge Graph.
By using this site, you agree to our Terms of Service.